International Study Characterizes Central Nervous System Involvement in Pediatric FIG4 Mutations

A retrospective analysis of 14 pediatric patients with biallelic FIG4 variants indicates that the mutations primarily manifest as severe neurodevelopmental disorders with cognitive and motor delays, redefining the clinical understanding beyond classic peripheral neuropathies.

Researchers retrospectively analyzed clinical, genetic, and neurophysiological data from 14 pediatric patients with biallelic FIG4 variants across an international multicentre cohort.

The study reported that instead of the typical peripheral neuropathy classically associated with pathogenic FIG4 variants, the predominant clinical presentation in this pediatric cohort was a severe neurodevelopmental disorder.

The evaluated pediatric patients exhibited profound motor and cognitive delays, with a subset displaying distinct central nervous system movement abnormalities such as dystonia and bradykinesia.

The findings establish that loss of functional FIG4 causes a broader and more severe disease spectrum with extensive central nervous system involvement than previously reported in the literature.

Recognizing these prominent features of intellectual disability and motor abnormalities expands the diagnostic considerations for clinicians evaluating pediatric patients with unmapped neurodevelopmental delays.

The clinical characterization of FIG4-related CNS pathology maps potential targets for rare neurodevelopmental and neurodegenerative disease interventions, but lacks direct implications for current longevity biotechnology portfolios.

None of the active preclinical programs from companies in the longevity knowledge base, including Genflow Biosciences and Rejuvenate Bio, are currently targeting FIG4 or its associated clinical phenotypes.